🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Safety and Efficacy of Eculizumab in High-risk TA-TMA NCT07707687Phase 28 sites📍 Changsha📍 Hangzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Eculizumab Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy NCT07347990NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: iptacopan Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy NCT06102694n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy